WallStreetZenWallStreetZen

NASDAQ: MMED
Minimed Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MMED

Based on 10 analysts offering 12 month price targets for Minimed Group Inc

Min Forecast
$16.00+3.43%
Avg Forecast
$21.20+37.04%
Max Forecast
$26.00+68.07%

Should I buy or sell MMED stock?

Based on 10 analysts offering ratings for Minimed Group Inc.

Strong Buy
Strong Buy
7 analysts 70%
Buy
2 analysts 20%
Hold
1 analysts 10%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MMED's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MMED as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their MMED stock forecasts and price targets.

MMED stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-04
lockedlocked$00.00+00.00%2026-05-18
lockedlocked$00.00+00.00%2026-05-12
lockedlocked$00.00+00.00%2026-04-01
lockedlocked$00.00+00.00%2026-03-31
Piper Sandler
Bottom 3%
3
HoldInitiates Coverage On$16.00+3.43%2026-03-31
Mizuho
Top 8%
93
BuyInitiates Coverage On$21.00+35.75%2026-03-31
Morgan Stanley
Bottom 12%
12
Strong BuyInitiates Coverage On$19.00+22.82%2026-03-31
Evercore ISI Group
Top 32%
69
BuyInitiates Coverage On$20.00+29.28%2026-03-31
BTIG
Top 38%
63
Strong BuyInitiates Coverage On$25.00+61.60%2026-03-31

1 of 1

Forecast return on equity

Is MMED forecast to generate an efficient return?

Company
14.73%
Industry
23.19%
Market
169.41%
MMED's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MMED forecast to generate an efficient return on assets?

Company
11.74%
Industry
16.79%
MMED is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MMED earnings per share forecast

What is MMED's earnings per share in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$0.20
Avg 2 year Forecast
$0.66
Avg 3 year Forecast
$0.61

MMED revenue forecast

What is MMED's revenue in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$3.1B
Avg 2 year Forecast
$3.5B
Avg 3 year Forecast
$3.8B

MMED vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
MMED$15.47$21.20+37.04%Strong Buy
TXG$29.05$24.20-16.70%Buy
HNGE$64.75$69.33+7.08%Strong Buy
DOCS$20.02$30.38+51.75%Buy
WAY$18.45$33.38+80.89%Strong Buy
View Top Health Information Service Stocks

Minimed Group Stock Forecast FAQ

Is Minimed Group Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: MMED) stock is to Strong Buy MMED stock.

Out of 10 analysts, 7 (70%) are recommending MMED as a Strong Buy, 2 (20%) are recommending MMED as a Buy, 1 (10%) are recommending MMED as a Hold, 0 (0%) are recommending MMED as a Sell, and 0 (0%) are recommending MMED as a Strong Sell.

If you're new to stock investing, here's how to buy Minimed Group stock.

What is MMED's earnings growth forecast for 2026-2028?

(NASDAQ: MMED) Minimed Group's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 26.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.99%.

Minimed Group's earnings in 2026 is N/A.On average, 13 Wall Street analysts forecast MMED's earnings for 2026 to be $56,894,130, with the lowest MMED earnings forecast at -$96,321,256, and the highest MMED earnings forecast at $138,584,664. On average, 14 Wall Street analysts forecast MMED's earnings for 2027 to be $185,846,668, with the lowest MMED earnings forecast at $77,057,005, and the highest MMED earnings forecast at $271,272,108.

In 2028, MMED is forecast to generate $171,356,357 in earnings, with the lowest earnings forecast at $27,520,359 and the highest earnings forecast at $259,477,669.

What is MMED's revenue growth forecast for 2026-2028?

(NASDAQ: MMED) Minimed Group's forecast annual revenue growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.81%.

Minimed Group's revenue in 2026 is N/A.On average, 14 Wall Street analysts forecast MMED's revenue for 2026 to be $884,021,322,224, with the lowest MMED revenue forecast at $847,233,903,796, and the highest MMED revenue forecast at $912,945,780,988. On average, 14 Wall Street analysts forecast MMED's revenue for 2027 to be $979,219,298,156, with the lowest MMED revenue forecast at $932,322,360,160, and the highest MMED revenue forecast at $1,012,075,236,752.

In 2028, MMED is forecast to generate $1,057,568,074,808 in revenue, with the lowest revenue forecast at $1,009,267,036,872 and the highest revenue forecast at $1,106,430,752,720.

What is MMED's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MMED) forecast ROA is 11.74%, which is lower than the forecast US Health Information Services industry average of 16.79%.

What is MMED's Price Target?

According to 10 Wall Street analysts that have issued a 1 year MMED price target, the average MMED price target is $21.20, with the highest MMED stock price forecast at $26.00 and the lowest MMED stock price forecast at $16.00.

On average, Wall Street analysts predict that Minimed Group's share price could reach $21.20 by Jun 4, 2027. The average Minimed Group stock price prediction forecasts a potential upside of 37.04% from the current MMED share price of $15.47.

What is MMED's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MMED) Minimed Group's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that MMED's EPS will be $0.20 for 2026, with the lowest EPS forecast at -$0.34, and the highest EPS forecast at $0.49. On average, analysts forecast that MMED's EPS will be $0.66 for 2027, with the lowest EPS forecast at $0.27, and the highest EPS forecast at $0.97. In 2028, MMED's EPS is forecast to hit $0.61 (min: $0.10, max: $0.92).

What is MMED's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MMED) forecast ROE is 14.73%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.